Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / EIDX - Eidos launches late-stage study of AG10 in ATTR-CM

EIDX - Eidos launches late-stage study of AG10 in ATTR-CM

Eidos Therapeutics Inc.
  • Eidos Therapeutics (NASDAQ:EIDX) initiates a Phase 3 clinical trial, ATTRibute-CM, evaluating lead candidate AG10 in patients with transthyretin amyloid cardiomyopathy (ATTR-CM).
  • More news on: Eidos Therapeutics, Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: Eidos Therapeutics Inc.
Stock Symbol: EIDX
Market: NASDAQ
Website: eidostx.com
Menu
EIDX EIDX Quote EIDX Short EIDX News EIDX Articles EIDX Message Board
Get EIDX Alerts

News, Short Squeeze, Breakout and More Instantly...